Ivermectin study shows real promise in fight against covid

Mainstream Media will not tell you this. 

In a pandemic where the SA Government blatantly discouraged the use of Hydroxychloroquine and also Ivermectin, but jumped at a Bill Gates vaccine that is new technology (never used on humans before which is communicating with human’s DNA without the known long term effects of this) just doesn’t make any sense.

Ivermectin can be given to people at a fraction of covid prices, locally manufactured in SA and does not affect one’s DNA. It also has been around for decades and the people who invented it got a Nobel prize for it. See the excerpt from Brittanica:
anthelmintic compounds avermectin and ivermectin, which proved vital to the control of certain parasitic infections in humans and other animals. For his discoveries, Campbell was awarded the 2015 Nobel Prize for Physiology or Medicine (shared with Japanese microbiologist Ōmura Satoshi and Chinese scientist Tu Youyou). https://www.britannica.com/science/ivermectin

Christians do your own research. Several other trials all over the world has reported similar effects. Have a look at the studies we just found below with a quick google search. Studies 2-4 can be found here US National Library of Medicine National Institutes of Health. You can follow the links.

A small Indian clinical trial showed that Ivermectin reduced covid infections with 73%.

The results shows promise, even though it still needs peer review.

Here is the link to the Indian study.

The extract is as follows:



Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in COVID-19 infection. The study was aimed to explore the association between ivermectin prophylaxis and development of COVID-19 infection among healthcare workers.


A hospital-based matched case-control study was conducted among healthcare workers of AIIMS Bhubaneswar, India, from September to October 2020. Profession, gender, age and date of diagnosis were matched for 186 case-control pairs. Cases and controls were healthcare workers who tested positive and negative, respectively, for COVID-19 by RT-PCR. Exposure was defined as the intake of ivermectin and/or hydroxychloroquine and/or vitamin-C and/or other prophylaxis for COVID-19. Data collection and entry was done in Epicollect5, and analysis was performed using STATA version 13. Conditional logistic regression models were used to describe the associated factors for COVID-19 infection.


Ivermectin prophylaxis was taken by 77 controls and 38 cases. Two-dose ivermectin prophylaxis (0.27, 95% CI, 0.15-0.51) was associated with 73% reduction of COVID-19 infection among healthcare workers for the following one month, those who were involved in physical activity (3.06 95% CI, 1.18-7.93) for more than an hour/day were more likely to contract COVID-19 infection. Type of household, COVID duty, single-dose ivermectin prophylaxis, vitamin-C prophylaxis and hydroxychloroquine prophylaxis were not associated with COVID-19 infection.

Conclusion Two-dose ivermectin prophylaxis at a dose of 300 μg/kg with a gap of 72 hours was associated 73% reduction of COVID-19 infection among healthcare workers for the following one-month. Further research is required before its large scale use.

DOMINICAN REPUBLIC STUDY: Ivermectin was administered in 1,300 early stage COVID-19 patients. Treatment began with standard dose of 100–200 mcg/kg and have escalated that to 400 mcg/kg. Some of the patients also received azithromycin.99% of them were cured. Average duration of full infection went down from 21 days to 10 days. Ivermectin starts inhibiting the virus within a couple days in humans. Only side effects reported were mild heart burn and diarrhea.

Trial Site News [Internet] President of Dominican republic’s largest private health group discusses the success of ivermectin as a treatment for early stage COVID-19. 2020 Jun. https://www.trialsitenews.com/president-of-dominican-republics-largest-private-health-group-discusses-the-success-of-ivermectin-as-a-treatment-for-early-stage-covid-19/ [cited 19 July 2020]. Available from: [Ref list]

BANGLADESH STUDY: RCT involving mild to moderate degree of COVID-19 patients Study groups, A (n = 60): Ivermectin 200 mcg/kg single dose + Doxy 100mg BID for 10 days; and B (n = 56): HCQ 400 mg 1st day, then 200mg BID for 9 days + Azithromycin 500mg daily for 5 Days. Treatment outcomes were evaluated on 5th day in case of asymptomatic patients and 2nd non-symptomatic day onward from 1st day of the drug intake. Outcome: Group A vs. Group-B: Recovery rate was 100% vs 96.36%, mean symptomatic recovery duration was 5.93 days’ vs 6.99 days, negative PCR was achieved on 8.93 days vs. 9.33 days, and by 5th day, 55.10% vs23.8% of patients gained symptomatic recovery. 

Chowdhury A.T., Shahbaz M., Karim M.R., Islam J., Dan G., He S. A comparative observational study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients [Preprint] 2020. https://www.researchgate.net/publication/342159343 [cited 2020 July 19]. Available from: [Ref list]

USA STUDY I:Printed in Medscape (Jul 15, 2020, Author: David J Cennimo, MD, FAAP, FACP, AAHIVS; Chief Editor: Michael Stuart Bronze, MD.) Ivermectin at four Florida hospitals showed significantly lower mortality rates in those who received ivermectin compared with usual care (15% vs 25.2%; P = 0.03). It was a retrospective cohort study (n = 280) in hospitalized patients with confirmed SARS-CoV-2 infection. Ivermectin, showed in vitro reduction of viral RNA in Vero-hSLAM cells 2 hours’ post-infection with SARS-CoV-2 clinical isolate Australia/VIC01/2020. The mortality rate was also lower among 75 patients with severe pulmonary disease treated with ivermectin (38.8% vs 80.7%; P = 0.001), although the rate of successful extubation did not differ significantly. , 


Cennimo David J. What is the role of antiparasitic drug ivermectin in the treatment of corona virus disease 2019 (Covid-19)? https://www.medscape.com/answers/2500114-197513/what-is-the-role-of-the-antiparasitic-drug-ivermectin-in-the-treatment-of-coronavirus-disease-2019-covid-19 Updated: Jul 02, 2020. [Internet] [cited 2020 July 19]. Available from: [Ref list]

Rajter J.C., Sherman M., Fatteh N., Vogel F., Sacks J., Rajter J.J. ICON (Ivermectin in COvid Nineteen) study: use of ivermectin is associated with lower mortality in hospitalized patients with COVID-19 [medRxiv Preprint] 2020 Jun. [cited: 2020 July 19] [CrossRef] [Ref list]


Amazingly SAHPRA refused to allow the use of Ivermectin, saying there was no trials registered with them. They can’t find trusted studies. Instead, they criminally charge anyone who tries to use it against covid19.
You decide for yourself if this makes sense in this so-called state of “disaster”.

CHRISTIANS BE FULLY INFORMED: Nuus.News has reported that Government is planning to vaccinate 40million innocent South Africans with an unproven, new technology vaccine
, that communicates with your DNA and that has been in trials for less than 6 months, from Bill Gates, a big proponent for depopulation and with a history of botched mass vaccinations.

Please go and vote on Gospel.Network if you don’t want forced vaccines.

Very little do Christian-haters know they are playing into the hands of the Antichrist’s One World Government which will give them a One World ID with the vaccine to become part of the One World Economy that will be ruled by the Antichrist through the Mark of the Beast on their right hands and foreheads as God has prophesied thousands of years ago already. The Bible says anyone who takes the mark of the Beast will never ever be able to go to heaven. They will be plunged into wickedness and will be tormented in the lake of fire forever. Revelation 14:9-11. Now we are starting to see the reality, with vaccines being targeted to people’s DNA, which could change how people behave/think. If the Christian haters only knew the praying Church is the only force stopping the Antichrist from taking over, they would change their tune.

Keep praying Church! Jesus is coming soon!

Leave a Reply

Your email address will not be published. Required fields are marked *